Skip to content
healthcare.dev
Get a free key

Unituxin

NDC 66302-014, DINUTUXIMAB, injection, from United Therapeutics Corporation.

Product NDC
66302-014
Status
Listed
Labeler
United Therapeutics Corporation
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125516
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66302-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DINUTUXIMAB3.5 mg/mL

Pharmacologic classes

Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]; Glycolipid Disialoganglioside-directed Antibody [EPC]

Package NDCNDC-11Package
66302-014-01663020014011 VIAL, SINGLE-DOSE in 1 BOX (66302-014-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d66bdf0d-9d65-45de-ae5b-a58617c27492

Use it

Look up 66302-014 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66302-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66302-014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.